View in EDS HTML Full Text PDF Full Text

JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC.

Saved in:
Bibliographic Details
Title: JMJD3 promotes esophageal squamous cell carcinoma pathogenesis through epigenetic regulation of MYC.
Authors: Li SM; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.; Department of Medical Oncology, Henan Cancer Hospital, the Affiliated Cancer Hospital of Zhengzhou University, Henan, PR China., He LR; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Chen JW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Zhou J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Nie RC; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Jin XH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Wang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China., Fu JH; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.; Guangdong Esophageal Cancer Institute, Guangzhou, PR China., Wang FW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China. wangfengw@sysucc.org.cn., Xie D; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China. xiedan@sysucc.org.cn.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, PR China. xiedan@sysucc.org.cn.
Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2020 Aug 25; Vol. 5 (1), pp. 165. Date of Electronic Publication: 2020 Aug 25.
Publication Type: Letter
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2059-3635
DOI:10.1038/s41392-020-00282-9